When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

HIV-related opportunistic infections

Last reviewed: 30 Nov 2025
Last updated: 11 Sep 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • no antiretroviral treatment (ART) or failure of ART
  • fever
  • headache and altered mental status
  • dyspnea or cough
  • abdominal pain, diarrhea, weight loss
  • dysphagia
  • lymphadenopathy
  • visual floaters, eye pain, and blindness
  • ocular hemorrhage
  • mucosal changes
Detalhes completos

Outros fatores diagnósticos

  • hepatosplenomegaly
  • exercise-induced oxygen desaturation
  • blurred vision and photophobia
  • papilledema
  • meningismus, focal neurologic findings
  • pain and weakness
  • bone or joint pain
  • skin lesions
Detalhes completos

Fatores de risco

  • post-HIV seroconversion with any CD4 count
  • CD4 count below 250 cells/microliter
  • CD4 count below 200 cells/microliter
  • CD4 count below 150 cells/microliter
  • CD4 count below 100 cells/microliter
  • CD4 count below 50 cells/microliter
  • no antiretroviral treatment (ART) or failure of ART
  • men who have sex with men (MSM)
  • black or Hispanic race
  • intravenous drug use
  • socioeconomic factors (poverty, overcrowding, homelessness, poor nutrition)
  • dust inhalation in areas endemic for Coccidioides and Histoplasma
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • CD4 cell count
  • sputum stain and culture
  • blood cultures
  • adenosine deaminase
  • Toxoplasma gondii serology
  • Coccidioides serology
  • cryptococcal polysaccharide antigen
  • Histoplasma capsulatum antigen
  • Histoplasma capsulatum culture
  • CBC
  • LFT
  • LDH
  • ABG
  • CXR
  • head CT
Detalhes completos

Tests to avoid

  • cytomegalovirus (CMV) serology
  • quantitative cytomegalovirus (CMV) polymerase chain reaction (PCR)
Detalhes completos

Investigações a serem consideradas

  • tuberculosis (TB) nucleic acid amplification
  • lateral flow urine lipoarabinomannan (LF-LAM) assay
  • bronchoalveolar lavage (BAL)
  • oropharyngeal scrapings (KOH prep) and culture
  • cerebrospinal fluid (CSF) analysis
  • polymerase chain reaction (PCR): cerebrospinal fluid (CSF), bronchoalveolar lavage (BAL) fluid, and vitreous and aqueous humor specimen for Toxoplasma gondii
  • bone marrow aspirate and culture
  • lymph node aspirate or biopsy
  • tissue biopsy
  • brain biopsy
  • abdominal CT
  • high-resolution CT (HRCT) of the chest
  • polymerase chain reaction (PCR) for Pneumocystis jirovecii pneumonia (PCP)
  • beta-D-glucan
  • brain MRI
  • thallium single photon emission tomography and PET
  • upper gastrointestinal endoscopy and colonoscopy
  • coccidioidal antigen testing
  • polymerase chain reaction (PCR) for Coccidioides
  • polymerase chain reaction (PCR) for Histoplasma
Detalhes completos

Algoritmo de tratamento

AGUDA

Mycobacterium tuberculosis infection

disseminated M avium complex

Pneumocystis jirovecii pneumonia

Toxoplasma gondii infection encephalitis

cryptococcal meningitis

cytomegalovirus

mucocutaneous candidiasis

coccidioidomycosis

disseminated histoplasmosis

Colaboradores

Autores

Jake Scott, MD

Clinical Associate Professor

Infectious Diseases and Geographic Medicine

Stanford University School of Medicine

Antimicrobial Stewardship Program Medical Director

Stanford Health Care Tri-Valley

Pleasanton

CA

Declarações

JS declares that he has no competing interests.

Agradecimentos

Dr Jake Scott would like to gratefully acknowledge Dr, Ruth Byrne, Dr Mark Nelson, and Dr Irene Alexandraki, previous contributors to this topic.

Declarações

RB, MN, and IA declare that they have no competing interests.

Revisores

Thomas B. Campbell, MD

Professor of Medicine

University of Colorado Anschutz

Aurora

CO

Declarações

Unpaid member of the US DHHS Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV and the National Comprehensive Cancer Network Guidelines for Cancer in People with HIV and Kaposi Sarcoma.

Ellen Kitchell, MD, FIDSA, AAHIVM-S

Associate Professor

University of Texas Southwestern

Dallas

TX

Declarações

EK declares that she has no competing interests.

Colm O'Mahony, MD, FRCP, BSc, DIPVen

Consultant in Sexual Health

Department of Sexual Health

Countess of Chester Hospital NHS Foundation Trust

Chester

UK

Declarações

CO declares that he has no competing interests.

Nicola Steedman, MRCP, DipGUM, DipHIV

Consultant Physician in Sexual Health and HIV

Department of Sexual Health

Countess of Chester Hospital NHS Foundation Trust

Chester

UK

Divulgaciones

NS declares that she has no competing interests.

William R. Rodriguez, MD

Assistant Professor of Medicine

Massachusetts General Hospital

Charlestown

MA

Divulgaciones

WRR declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. 2025 [internet publication].Texto completo

World Health Organization. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Jun 2022 [internet publication].Texto completo

Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416.Texto completo  Resumen

Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007 Oct 1;45(7):807-25.Texto completo  Resumen

Chang CC, Harrison TS, Bicanic TA, et al. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. Lancet Infect Dis. 2024 Aug;24(8):e495-512.Texto completo  Resumen

Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1-50.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Diferenciales

    • Pneumonia
    • Diarrhea
    • Meningitis
    Más Diferenciales
  • Guías de práctica clínica

    • Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV
    • Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the International Antiviral Society–USA panel
    Más Guías de práctica clínica
  • Folletos para el paciente

    Tuberculosis

    Toxoplasmosis in pregnancy: what is it?

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad